Language: BG BG
← Back to results
Recruiting NCT07069400

An International Observational Study of Adults With Acute Infection

Conditions: Infectious Disease

Sponsor: University of Minnesota

trial.available_in: БГ
Overview
Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.
Who can participate
Inclusion Criteria: * Age ≥18 years old * Admitted to hospital (or in an emergency department with anticipated hospital admission) for the management of a suspected or confirmed acute infectious disease. * Onset of symptoms of an infectious disease within the past 30 days. * Informed consent for study participation by the participant or a surrogate decision maker if the participant lacks capacity for consent. Exclusion Criteria: * Current imprisonment (this does not include quarantine for an infectious disease). * Patient undergoing comfort care measures only such that treatment focuses on end- of-life symptom management over prolongation of life. * Expected inability or unwillingness to participate in study procedures. * In the opinion of the investigator, participation in the study is not in the best interest of the patient.
Locations 16
Argentina (1)
Instituto Medico Platense (611-025)
La Plata , Buenos Aires
Australia (1)
Royal Prince Alfred Hospital (612-056)
Camperdown , New South Wales
Brazil (1)
Associaco Beneficente Siria - HCor (649-203)
São Paulo , São Paulo
Côte d’Ivoire (1)
CERMIPA (Site 403-001)
Abidjan
Denmark (1)
Rigshospitalet, CHIP (625-006)
Copenhagen
France (1)
Hospices Civiles de Lyon (631-033)
Lyon
Greece (1)
Evangelismos General Hospital (Site 635-020)
Athens , Attica
Japan (1)
Fujita Health University Hospital
Toyoake , Aichi-ken
Singapore (1)
Tan Tock Seng Hospital
Singapore
South Korea (1)
Seoul National University Bundang Hospital
Seongnam-si , Gyeonggi-do
Spain (1)
Hospital Universitari Germans Trias i Pujol (Site 626-003)
Badalona , Barcelona
Thailand (1)
Chulalongkorn University and The HIV-NAT (Site 613-001)
Bangkok
Uganda (1)
MRC/UVRI & LSHTM Uganda Research Unit (Site 634-601)
Entebbe
Ukraine (1)
Central City Clinical Hospital of Ivano-Frankivsk City Council (627-302)
Ivano-Frankivsk
United Kingdom (1)
Royal Free Hospital (Site 634-006)
London
United States (1)
Banner University Medical Center Tucson
Tucson , Arizona
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
25.08.2025
Completion date
08.06.2027
Registry ID
NCT07069400
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.